Thomas Beetham - Title: Chief Legal Officer and Secretary at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Chief Legal Officer and Secretary
Stock Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Beetham since 7/7/2023

Holdings reported by Thomas Beetham for Dianthus Therapeutics, Inc. /DE/

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 19,897 $239 K $12.00 Nov 30, 2022 Direct
Stock Option (Right to Buy) 75,000 Aug 1, 2022 Direct Common Stock

Transactions reported by Thomas Beetham for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership